Journal article icon

Journal article

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.

Abstract:
Although meningococcal disease caused by serogroup B remains an important public health concern, a licensed vaccine providing broad protection against this pathogen is not yet available. Advances in genomics have paved the way for the discovery of new vaccine candidates for inclusion into a multicomponent serogroup B vaccine. In this article, we will review recent advances in the development of these vaccines, focussing particularly on one of the 'next generation' MenB vaccines, 4CMenB.

Actions


Access Document


Publisher copy:
10.1586/erv.11.32

Authors


Journal:
Expert review of vaccines
Volume:
10
Issue:
5
Pages:
575-588
Publication date:
2011-05-01
DOI:
EISSN:
1744-8395
ISSN:
1476-0584
Source identifiers:
191281
Language:
English
Keywords:
Pubs id:
pubs:191281
UUID:
uuid:3c3b1ab3-c315-411c-840b-75562545aa62
Local pid:
pubs:191281
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP